Our nationally-commissioned pulmonary hypertension service at Hammersmith Hospital consists of a highly specialised multidisciplinary team providing diagnosis, investigations, outpatient and inpatient treatment, and long-term follow-up care for people with suspected pulmonary hypertension.
We are one of only eight trusts in the UK to offer this dedicated service. We strive to improve the quality of life and the personal experience of our patients and their carers by using the best evidenced-based practice.
We participate in the national audit programme for pulmonary hypertension services – visit NHS Digital’s website to learn more and read the latest audit results.
Conditions and treatments
At Hammersmith Hospital we accept referrals of adults with pulmonary hypertension where the following diagnoses are suspected or proven:
- pulmonary arterial hypertension
- chronic thromboembolic pulmonary hypertension and other pulmonary artery obstructions
- pulmonary hypertension related to left heart disease or parenchymal lung disease with signs of severe pulmonary hypertension/right ventricular dysfunction
- miscellaneous/uncertain causes
- pulmonary hypertension where the cause is not certain
Pulmonary hypertension disease targeted therapies are offered to appropriate patients in accordance with the national commissioning policy and current evidence-based guidelines.
Patients diagnosed with chronic thromboembolic pulmonary hypertension are referred to Royal Papworth Hospital for an opinion about their suitability for pulmonary endarterectomy surgery. Patients that may benefit from a lung transplantation are referred to Harefield or Royal Papworth Hospital for assessment.
We conduct the following tests
- six minute walk test
- electrocardiogram (ECG)
- chest x-ray
- quality of life questionnaire
- screening blood tests
- MRSA screening swabs
Further investigations may include
- CT pulmonary angiography
- ventilation perfusion scanning
- cardiac magnetic resonance
- selective pulmonary angiography
- abdominal ultrasound
- pulmonary function tests
- arterial blood gases
- cardiopulmonary exercise testing
- cardiac catheterisation +/- exercise
- exercise echocardiography
- overnight oxygen saturation monitoring
Visit our patient information page for more information.
Clinical trials and research
We offer clinical research to many of our patients, from phase I to phase IV. All research is approved by research ethics committees via the NHS health research authority. Patients will be provided with written information about the research and given time to consider their options. Opportunities will be provided to discuss this further with the doctors involved.
The pulmonary hypertension team at Hammersmith Hospital provide training and education about the condition for all healthcare professionals, including annual study days and an annual masterclass for physicians. Please email firstname.lastname@example.org with any questions.
Further online resources
- Outpatients appointments
- 020 3313 1314
Read the full story
Protein can identify heart patients at increased risk of death
A protein linked to heart attacks can identify which patients with an irregular heart beat have an increased risk of death, new research shows. The study, by researchers from the National Institute of Health Research Health Informatics…
Read the full story
Small rise in heart attack protein linked to increased risk of early death in all age groups
A new analysis of patients’ heart data at Imperial College Healthcare NHS Trust has shown that even a slight increase in a protein linked to heart attacks, called troponin, is linked to an increased risk of early death at all ages.
Read the full story
Secretary of State for Health and Social Care opens new emergency lift for cardiac patients
A new emergency lift has been installed at Hammersmith Hospital’s heart attack centre (HAC) after a former patient raised almost £100,000 towards the project.